Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Blood Pressure01:30

Blood Pressure

Blood pressure (BP) is the pressure or force of blood exerted on the artery's walls as it circulates through the body. It is essential for maintaining blood flow throughout the body.
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Phaeochromocytoma and paraganglioma].

La Revue de medecine interne·2019
Same author

Prevalence of human T cell lymphotropic virus 1 infection in Canada.

Current oncology (Toronto, Ont.)·2019
Same author

Utility of the QuantiFERON-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2016
Same author

European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma.

European journal of endocrinology·2016
Same author

A genome-wide association study of pulmonary tuberculosis in Morocco.

Human genetics·2016
Same author

[Angioplasty for atherosclerotic renal artery stenosis: the end of the story?].

La Revue de medecine interne·2014

Related Experiment Video

Updated: Jun 10, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

[Endocrine hypertension].

L Amar1, C Lepoutre, G Bobrie

  • 1Unité d'hypertension artérielle, hôpital européen Georges-Pompidou, AP-HP, université Paris Descartes, 75908 Paris cedex 15, France. Laurence.amar@egp.aphp.fr

La Revue De Medecine Interne
|August 3, 2010
PubMed
Summary

Endocrine hypertension, a common cause of secondary hypertension, includes primary aldosteronism, paraganglioma, and Cushing's syndrome. Early screening and diagnosis are crucial for identifying and treating potentially curable forms of hypertension.

Related Experiment Videos

Last Updated: Jun 10, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Area of Science:

  • Endocrinology
  • Nephrology
  • Internal Medicine

Context:

  • Endocrine hypertension accounts for over half of secondary hypertension cases.
  • Includes primary aldosteronism, paraganglioma/pheochromocytoma, and Cushing's syndrome.
  • Screening is vital for patients with resistant or severe hypertension, or hypertension with adrenal abnormalities.

Purpose:

  • To outline the screening, diagnosis, and management of endocrine hypertension.
  • To emphasize the importance of identifying surgically correctable causes of hypertension.
  • To differentiate between various endocrine causes and their specific treatments.

Summary:

  • Screening involves hormone measurements and adrenal imaging (CT scans).
  • Primary aldosteronism is a frequent cause, often presenting solely with hypertension.
  • Pheochromocytoma and Cushing's syndrome are rare and require specialized care.
  • Bilateral adrenal hyperplasia is treated with mineralocorticoid receptor antagonists.
  • Lateralized aldosterone secretion may be managed with adrenalectomy for potential hypertension cure.

Impact:

  • Enables diagnosis of surgically correctable hypertension, unlike essential hypertension.
  • Facilitates targeted treatment, improving patient outcomes.
  • Highlights the challenges and importance of accurate diagnosis and management in endocrine hypertension.